Martin Shkreli Avoids Congressional Drug Price Hearings; Valeant Interim CEO Plans To Appear
January 21, 2016 at 11:00 AM EST
Former Turing Pharmaceuticals CEO Martin Shrkeli has refused to comply with a subpoena to testify in front of a Senate panel, which ...